MarginsXMarginsX
Home › Markets › Health Care › BAX

Baxter International Inc. (BAX)

BAX trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$25.54
-1.05% on the day
Market cap
$13.2B
Large cap
Revenue · 2025
$11.2B
+5.7% on 2024
Net income · 2025
-$957.0M
-8.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/0001628280-26-007733-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerBAX on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000010456
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$11.2B
Net income-$957.0M
Operating income-$308.0M
Net margin-8.5%
Operating margin-2.7%
Revenue growth+5.7%
Cash$2.0B
Total assets$20.1B
P/E (computed)Net income was not positive
P/S (computed)1.2×

Warning signs

Cash runway
Cash-flow positive
$2.0B cash at September 30, 2026
Share count, 1 year
+0.6%
2025-10-31 to 2026-10-22 · +2.0% over 3 years
Going-concern doubt
No
10-Q filed October 29, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-29
Cash and burn$2.0B cash; operating cash flow $410.0M a quarter.Report 2026-09-30
Shares outstanding517,348,188 (2026-10-22); 514,055,805 a year earlier; 507,323,509 three years earlier.Cover page 2026-10-22
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2025-05-30
AuditorPricewaterhouseCoopers LLP, Chicago, Illinois, United StatesPCAOB Form AP 2026-02-27
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$3.0B$294.0M$558.0M$2.0B$844.0M$11.6B10-Q 2026-10-29
Q2 2026
2026-06-30
$3.0B$126.0M$285.0M$2.1B$844.0M$11.5B10-Q 2026-07-30
Q1 2026
2026-03-31
$2.7B-$15.0M$213.0M$2.0B$842.0M$11.3B10-Q 2026-04-30
Q4 2025
2025-12-31
$3.0B-$1.1B$584.0M$2.0B$9.4B$11.2B10-K 2026-02-12
Q3 2025
2025-09-30
$2.8B-$46.0M$237.0M$1.7B$755.0M$11.0B10-Q 2026-10-29
Q2 2025
2025-06-30
$2.8B$91.0M$217.0M$1.7B$8.0M$10.9B10-Q 2026-07-30
Q1 2025
2025-03-31
$2.6B$126.0M-$193.0M$2.3B$662.0M$10.8B10-Q 2026-04-30
Q4 2024
2024-12-31
$2.8B-$512.0M$488.0M$1.8B$15.3B$10.6B10-K 2025-02-21

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B22025-11-20
Latest annual report10-K2026-02-12
Latest quarterly / interim10-Q2026-10-29
Latest current report8-K2026-10-29
Latest proxyDEFA14A2026-04-29

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.1%
1 month+3.7%
3 months-4.6%
Year to date+35.1%
1 year+38.0%
From 52-week high-9.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
PENPenumbra Inc.$320.62-0.09%$12.6B
GKOSGlaukos Corporation$244.88-0.34%$14.5B
SOLVSolventum Corporation$88.65-0.48%$15.0B
PODDInsulet Corporation$145.29-4.72%$10.1B
GMEDGlobus Medical Inc.$70.50-2.27%$9.3B
TFXTeleflex Incorporated$157.10+1.51%$6.2B
WSTWest Pharmaceutical Services Inc.$417.80+0.33%$29.1B
DXCMDexCom Inc.$81.61-2.06%$30.4B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier